Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,961 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06792149 | Prediction of Drug Response in Gastric Cancer Based on 3D Bioprinting | unknown | — | 60 | Peking Union Medical College HospitalOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06562140 | Multidimensional Examination of Patients with Colorectal and Anal Cancer(MECACP) | unknown | — | 300 | University of PecsOTHER | 1 | Jan 23, 2025 |
| clinicaltrials |
| NCT06773260 | Liver and Spleen Stiffness to Predict the Presence of Esaphageal Varices in Cirrhotic With Advanced HCC(ELASTO-HCC) | unknown | — | 150 | Azienda Ospedaliero Universitaria Policlinico ModenaOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT06784401 | Oncologic and Functional Outcome and Quality of Life in Patients Treated for Laryngeal Cancer | unknown | — | 20 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT06353061 | Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer | unknown | Phase 2 | 51 | Peking Union Medical College HospitalOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06771947 | Predicting Symptom Trajectories After Thoracoscopic Lung Cancer Surgery Using an Interpretable Machine Learning Model | unknown | — | 1,500 | Guangdong Provincial People's HospitalOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT01753414 | Radical Resection Vs. Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLC(POSTILV) | unknown | Phase 2 | 44 | Radiation Therapy Oncology GroupNETWORK | 1 | Jan 6, 2025 | clinicaltrials |
| NCT06454175 | A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years | unknown | Phase 1 | 72 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Jan 6, 2025 | clinicaltrials |
| NCT06216743 | PRE- MISTIC: MRI and Cine Imaging to Improve Staging of Tumors in the Colon(PRE-MISTIC) | unknown | N/A | 15 | Radboud University Medical CenterOTHER | 1 | Dec 31, 2024 | clinicaltrials |
| NCT05922345 | Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy. | unknown | Phase 3 | 518 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Dec 30, 2024 | clinicaltrials |
| NCT06311357 | Percent Weight Change in the Medical Supplement Group of Early Breast Cancer | unknown | N/A | 40 | Department of Medical Services Ministry of Public Health of ThailandOTHER_GOV | 1 | Dec 27, 2024 | clinicaltrials |
| NCT06237257 | A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer | unknown | Phase 2 | 56 | Shanghai Shengdi Pharmaceutical Co., LtdINDUSTRY | 1 | Dec 24, 2024 | clinicaltrials |
| NCT06403111 | FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC | unknown | Phase 2 | 62 | Changzhou No.2 People's HospitalOTHER | 1 | Dec 20, 2024 | clinicaltrials |
| NCT06470672 | Study of SHR-A1921 Combined Adebrelimab in HR-positive, HER2-negative Advanced Breast Cancer | unknown | Phase 2 | 32 | Fudan UniversityOTHER | 1 | Dec 20, 2024 | clinicaltrials |
| NCT04660929 | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | unknown | Phase 1 | 48 | Carisma Therapeutics IncINDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT06741150 | NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients. | unknown | N/A | 18 | Newish Technology (Beijing) Co., Ltd.INDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT06736678 | Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer Patients | unknown | N/A | 98 | Sun Yat-sen UniversityOTHER | 1 | Dec 17, 2024 | clinicaltrials |
| NCT06733311 | A Study Developing a Non-invasive Urine-based Proteomic Model for Early Lung Cancer Detection.(UPD-LC) | unknown | — | 480 | Beijing Chao Yang HospitalOTHER | 1 | Dec 13, 2024 | clinicaltrials |
| NCT05215665 | GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma | unknown | N/A | 146 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 11, 2024 | clinicaltrials |
| NCT06250244 | 177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer | unknown | Phase 1 / Phase 2 | 12 | Peking Union Medical College HospitalOTHER | 1 | Dec 11, 2024 | clinicaltrials |
| NCT06729814 | Prospective Assessment of Acute Skin Toxicities in Breast Cancer Patients Undergoing Retreatment with 40 Gy in 15 Fractions Radiation Therapy | unknown | — | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 11, 2024 | clinicaltrials |
| NCT06724835 | Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T) | unknown | Phase 1 | 18 | Shenzhen Celconta Life Science Co., Ltd.INDUSTRY | 1 | Dec 9, 2024 | clinicaltrials |
| NCT03108196 | Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder | unknown | N/A | 96 | Zhujiang HospitalOTHER | 1 | Dec 4, 2024 | clinicaltrials |
| NCT04551495 | Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE)(ROSALINE) | unknown | Phase 2 | 65 | Jules Bordet InstituteOTHER | 2 | Dec 4, 2024 | clinicaltrials |
| NCT06143553 | Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer | unknown | Phase 3 | 168 | Shanghai Yizhong Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 29, 2024 | clinicaltrials |
| NCT06541314 | Fluzoparib Neoadjuvant Therapy for Ovarian Cancer | unknown | Phase 2 | 48 | Qilu Hospital of Shandong UniversityOTHER | 1 | Nov 27, 2024 | clinicaltrials |
| NCT06163963 | Sentinel Lymph Node in Early-Stage Endometrium Cancer | unknown | N/A | 100 | Istanbul UniversityOTHER | 1 | Nov 25, 2024 | clinicaltrials |
| NCT06703866 | Value-Based Medicine (VBM) for Lung Cancer(VBM) | unknown | — | 200 | European Institute of OncologyOTHER | 1 | Nov 25, 2024 | clinicaltrials |
| NCT06698783 | Practical Application and Evaluation of Fortimel in Oncology Patients | unknown | N/A | 2,000 | Peking Union Medical College HospitalOTHER | 1 | Nov 21, 2024 | clinicaltrials |
| NCT06697990 | Cerebrospinal Fluid Immune Microenvironment Mechanism in Anaplastic Lymphoma Kinase Positive Lung Cancer Patients | unknown | Phase 2 | 12 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Nov 20, 2024 | clinicaltrials |
| NCT06541301 | PICC-ports Versus Chest - Ports for Long Term Chemotherapy Deliverance in Oncology Patients(PICCHEST) | unknown | N/A | 852 | European Institute of OncologyOTHER | 1 | Nov 19, 2024 | clinicaltrials |
| NCT05980403 | Prediction of Lymph Node Status in Stage T1 Esophageal Squamous Cell Carcinoma(RENMIN-237) | unknown | — | 300 | Yongshun ChenOTHER | 1 | Nov 14, 2024 | clinicaltrials |
| NCT06525870 | Efficacy of Topical 85% TCA in the Treatment of LSIL After Low-grade Abnormality of Screening Test: a Randomized Controlled Trial(Trichlosil) | unknown | Phase 2 | 44 | Department of Medical Services Ministry of Public Health of ThailandOTHER_GOV | 1 | Nov 14, 2024 | clinicaltrials |
| NCT06539169 | FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases | unknown | — | 1,000 | xCuresINDUSTRY | 1 | Nov 14, 2024 | clinicaltrials |
| NCT06684795 | FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for Neurosurgery | unknown | Phase 2 | 40 | Rigshospitalet, DenmarkOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT05650242 | A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1106 in Advanced Solid Tumors | unknown | Phase 1 | 177 | Shandong Boan Biotechnology Co., LtdINDUSTRY | 1 | Nov 8, 2024 | clinicaltrials |
| NCT06677775 | Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy | unknown | — | 30 | Anhui Provincial HospitalOTHER_GOV | 1 | Nov 7, 2024 | clinicaltrials |
| NCT06678230 | Clinical Trial of Eribulin in Combination with Anrotinib for HER-2 Negative Locally Advanced or Metastatic Breast Cancer | unknown | Phase 2 | 40 | The First Hospital of Jilin UniversityOTHER | 1 | Nov 7, 2024 | clinicaltrials |
| NCT06339684 | HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis(HPVImmuno) | unknown | — | 120 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | Nov 5, 2024 | clinicaltrials |
| NCT02558946 | Physical Therapy for Men Undergoing Prostatectomy | unknown | N/A | 113 | Indiana UniversityOTHER | 1 | Nov 4, 2024 | clinicaltrials |
| NCT06410703 | CAN1012 Combined With PD-1 in Patients With Solid Tumors | unknown | Phase 1 / Phase 2 | 71 | Canwell Biotech LimitedINDUSTRY | 1 | Oct 31, 2024 | clinicaltrials |
| NCT06585527 | Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma | unknown | Phase 1 | 30 | Beijing Neurosurgical InstituteOTHER | 1 | Oct 31, 2024 | clinicaltrials |
| NCT06663228 | Rapid Histologic Assessment for Stereotactic Breast Biopsy: Enhancing Early Detection With Miniature Mass Spectrometry and AI | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Oct 29, 2024 | clinicaltrials |
| NCT02295085 | Fernald Community Cohort -18 Year Observational Study(FCC) | unknown | — | 9,782 | University of CincinnatiOTHER | 1 | Oct 26, 2024 | clinicaltrials |
| NCT05042128 | The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma(ASCEND) | unknown | Phase 2 | 158 | Australasian Gastro-Intestinal Trials GroupNETWORK | 2 | Oct 22, 2024 | clinicaltrials |
| NCT06646809 | Reducing Inflammatory Syndrome in Surgery - Colorectal (RISIS-CR) Trial(RISIS-CR) | unknown | Phase 3 | 80 | National University Hospital, SingaporeOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT06344923 | Peritoneum and Anterior Rectus Sheath Suturing and Ileostomy | unknown | N/A | 120 | Qilu Hospital of Shandong UniversityOTHER | 1 | Oct 16, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Jan 24, 2025source: clinicaltrials